Most Recent
Crown loses row over ATE policy as security in iProsperity’s $55M case
Crown Resorts has lost a fight against a proposal by funders for iProsperity Group's liquidators to put up an after-the-event insurance policy as security for costs in a case that seeks to recover $55 million in gambling losses.
OAIC won’t probe class action-style complaint over Optus data breach
The privacy watchdog has given a preliminary view that it won't investigate a class action-style complaint brought by Maurice Blackburn over a 2022 Optus data breach, citing its own proceedings, a court has heard.
NBL defeats preliminary discovery case by Illawarra Hawks, Melbourne Phoenix
A judge has stayed a bid by the Illawarra Hawks and Melbourne Phoenix basketball clubs for preliminary discovery to determine whether to pursue claims against the National Basketball League.
Takeovers Panel says Cosette can’t shutter Mayne’s Adelaide drug plant
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
Mayne, Cosette row to be decided on merits after panel resets merger clock
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
Mayne wins breathing room in fight to get Cosette merger over the line
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.
Cosette appeals loss over exit from $672M Mayne Pharma merger
Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.
Mayne Pharma wins suit over Cosette’s termination of $672M takeover
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.
Insurers lose bid to see Ashurst advice in Greensill dispute
Insurers Bond & Credit Company and Tokio Marine can't eyeball advice given by Ashurst to lender White Oak in a dispute over the collapse of supply chain finance company Greensill.
Privilege fight erupts in Greensill case over email repeating Ashurst advice
Lender White Oak has argued it can shield an email that repeats legal advice from Ashurst that was accidentally disclosed to insurers Bond & Credit Company and Tokio Marine, which it has sued over the collapse of supply chain finance company Greensill.